Physician profile
Nancy J Halnon
NPI 1215983614
$6,229.41
in general payments reported to CMS, 2019-2025
13 companies · $21.32 in 2025
The $21.32 reported for 2025 was less than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $25.06 · 2021: $535 · 2022: $176 · 2023: $1,297 · 2024: $4,026 · 2025: $21.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,700 · Travel and Lodging: $2,123 · Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,700.00 |
| Travel and Lodging | $2,122.73 |
| Food and Beverage | $522.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,700.00 | 2024 | |
| Actelion Pharmaceuticals, LTD | $1,269.03 | 2023 | Uptravi |
| Merck Sharp & Dohme LLC | $1,218.51 | 2024 | Verquvo |
| Ns Pharma, INC. | $588.05 | 2021-2023 | Viltepso |
| Sarepta Therapeutics, INC. | $183.79 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2022 | |
| Abbott Laboratories | $47.77 | 2024 | Cardiomems |
| Abiomed | $40.12 | 2024 | Impella |
| Itf Therapeutics LLC | $21.32 | 2025 | |
| Biogen, INC. | $19.84 | 2024 | Spinraza |
| Sobi, INC | $15.98 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Halnon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.